Apr 25, 2017 - Novartis AG (NVS) reported first-quarter 2017 core earnings of $1.13 per share, beating the Zacks Consensus Estimate of $1.10.
Apr 25, 2017 - Biogen Inc. (BIIB) reported better-than-expected results in the first-quarter of 2017. The company surpassed expectations both for earnings and sales.
Apr 25, 2017 - Without price increases or deals to boost earnings, the pharmaceuticals sector faces a weak earnings season.
Apr 25, 2017 - A big dividend raise isn't always the right move for a business.
Apr 25, 2017 - Amgen (AMGN) is seeing encouraging earnings estimate revision activity as of late and carries a favorable rank, positioning the company for a likely beat this season.
Apr 25, 2017 - Here we have four pharma companies that are set to report first-quarter results on Apr 26. Let's see how things are shaping up for this quarter.
Apr 24, 2017 - Celgene Corporation (CELG) is scheduled to report first-quarter 2017 results on Apr 27, before the opening bell.
Apr 24, 2017 - Results from Johnson and Johnson could be a warning sign for other drug makers, which are scheduled to report this week and the next.
Apr 24, 2017 - Agenus Inc. (AGEN) is expected to report first-quarter 2017 results later this month or early next month.
Apr 24, 2017 - How do Amgen and Pfizer stocks stack up against each other?